Trials / Completed
CompletedNCT00915525
Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 829 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the long term safety and effectiveness of botulinum toxin type A in treating patients with idiopathic overactive bladder with urinary incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | Botulinum toxin Type A 100U or 150U injected into the detrusor, after protocol specified criteria are met, and no more frequently than every 12 weeks. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2014-08-05
- Completion
- 2014-08-05
- First posted
- 2009-06-08
- Last updated
- 2019-04-30
- Results posted
- 2015-12-18
Locations
8 sites across 8 countries: United States, Belgium, Canada, Czechia, Germany, Poland, Russia, United Kingdom
Source: ClinicalTrials.gov record NCT00915525. Inclusion in this directory is not an endorsement.